Clinical Trials

NCT04858334 | RECRUITING | PHASE2
152 participants

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2021-06-22
Completion:
2027-10-31
Conditions
  • Pancreatic Acinar Cell Carcinoma
  • Pancreatic Adenosquamous Carcinoma
  • Pancreatic Squamous Cell Carcinoma
  • Resectable Pancreatic Acinar Cell Carcinoma
  • Resectable Pancreatic Adenocarcinoma
  • Resectable Pancreatic Adenosquamous Carcinoma
  • Resectable Pancreatic Carcinoma
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT04837716 | ACTIVE_NOT_RECRUITING | PHASE1
12 participants

Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2021-03-18
Completion:
2027-09-23
Conditions
  • Metastatic Lung Non-Small Cell Carcinoma
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IIIC Lung Cancer AJCC v8
  • Stage IV Lung Cancer AJCC v8
  • Stage IVA Lung Cancer AJCC v8
  • Stage IVB Lung Cancer AJCC v8
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT04556890 | RECRUITING | NA
54 participants

Pain and Major Depressive Disorder

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2023-03-01
Completion:
2027-12-31
Conditions
  • Major Depressive Disorder
  • Chronic Pain
Interventions
  • DEVICE
No Results Yet
NCT04550494 | ACTIVE_NOT_RECRUITING | PHASE2
29 participants

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2021-04-26
Completion:
2026-07-10
Conditions
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Castration-Resistant Prostate Carcinoma
  • Clinical Stage III Gastric Cancer AJCC v8
  • Clinical Stage IV Gastric Cancer AJCC v8
  • HER2-Positive Breast Carcinoma
  • Locally Advanced Breast Carcinoma
  • Locally Advanced Gastric Carcinoma
  • Locally Advanced Malignant Solid Neoplasm
  • Locally Advanced Ovarian Carcinoma
  • Locally Advanced Pancreatic Carcinoma
  • Locally Advanced Prostate Carcinoma
  • Metastatic Breast Carcinoma
  • Metastatic Gastric Carcinoma
  • Metastatic Malignant Solid Neoplasm
  • Metastatic Ovarian Carcinoma
  • Metastatic Pancreatic Carcinoma
  • Metastatic Prostate Carcinoma
  • Platinum-Sensitive Ovarian Carcinoma
  • Recurrent Breast Carcinoma
  • Recurrent Gastric Carcinoma
  • Recurrent Ovarian Carcinoma
  • Recurrent Pancreatic Carcinoma
  • Recurrent Prostate Carcinoma
  • Stage II Pancreatic Cancer AJCC v8
  • Stage III Ovarian Cancer AJCC v8
  • Stage III Pancreatic Cancer AJCC v8
  • Stage III Prostate Cancer AJCC v8
  • Stage IV Ovarian Cancer AJCC v8
  • Stage IV Pancreatic Cancer AJCC v8
  • Stage IV Prostate Cancer AJCC v8
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT04526782 | ACTIVE_NOT_RECRUITING | PHASE2
119 participants

ENCOrafenib With Binimetinib in bRAF NSCLC

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2021-01-19
Completion:
2025-07-16
Conditions
  • Non Small Cell Lung Cancer
  • BRAF V600E
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page